Abiopharma

News list

📋 Patel Anish (Officer) plans to sell 100K shares of Enliven Therapeutics, Inc. (at $30.81 each, total $3.1M) Filed: Mar 24, 2026 | ID: 000025

Full text

News bot March 24, 2026, 8:26 p.m.
📋 Form 144 Filing: Patel Anish

Company: Enliven Therapeutics, Inc.

Filing Date: 2026-03-24

Relationship: Officer
Planned Sale Details:
- Security: Common
- Shares to be Sold: 100,000
- Price per Share: $30.81
- Total Value: $3,081,000.00
- Planned Sale Date: 2026-03-24
- Broker: Jefferies LLC
- Exchange: Nasdaq
Additional Information:
- SEC File Number: 001-39247
- Issuer Contact Phone: 720-647-8519
- Issuer Address: 6200 LOOKOUT ROAD, BOULDER, CO, 80301
- Broker Address: 520 Madison Ave, 4th Fl, New York, NY, 10022
- Shares Outstanding: 59000000.0
- Number of Securities to be Sold: 1
- Number of Past Sales: 1
- Remarks: The shares in this filing will be sold by The Patel/Dong Family Trust UAD 08/24/17.